I agree, they need to have it lifted, and I agree it should have been done before now, but the financials are the first step toward that. They are also a pleasant departure from the past policy of non-transparency.
While I'm sure that CVS would be much more inclined to sell a product that is well advertised, (they'd probably be selling it now if it was) their shelves are full of products that aren't.
With that in mind, why slam Identa when their rep does a decent job of getting the word out? Let's call a spade a spade. In the last several months, I can't recall a single outlandish pr that appears to be more the "best-case-scenario" of something being talked about, rather than reality. I am optimistic this is the prelude of sound PRs and solid growth and the financials are a good indication this may really be the case...I hope:)
Market Data 
Markets 
AI
